Clinical Trials Directory

Trials / Completed

CompletedNCT05277584

Analysis of Factors Determining Increase of Serum Sodium in Hyponatremic Patients

Prediction of Timely Evolution of Plasma Sodium in Treatment of Hyponatremia - Post Hoc-analysis of the Hyponatremia Registry

Status
Completed
Phase
Study type
Observational
Enrollment
3,460 (actual)
Sponsor
University of Cologne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to further analyse the dataset of the Hyponatremia Registry, a multicenter, prospective, observational study conducted between September 2020 and February 2013 in the United States of America and the European Union. The primary interest was to provide evidence to investigators' hypothesis that baseline sodium levels are a predominant factor determining the rapidity of sodium increase irrespective of the given treatment. Further investigators aimed to identify other independent predictors of the increase of plasma sodium upon treatment.

Detailed description

Hyponatremia is the most common electrolyte disorder in outpatients and hospitalized patients. Overly rapid sodium increase is associated with increased risk for osmotic demyelination. Smaller analyses have suggested that the slope of the sodium increment is higher with lower baseline sodium levels but this has not been confirmed in large datasets. Investigators have recently published the results of analysis on patients from the Otsuka HN-Registry on thiazide-induced hyponatremia (cooperation with Otsuka). In that dataset was founded the same association and there had been hints that this relationship holds true for all kinds of treatment including no treatment at all. Investigators took the datasets of those patients presenting with Hyponatremia that could be classified into one etiology group by the treating physician for further analysis. Patients with euvolemic, hypervolemic, hypovolemic or thiazide-associated HN were included in investigators' analysis. Furthermore investigators only considered those cases in which the patient record provided at least one documented plasma \[Na+\] within \<25 hours after the first plasma \[Na+\] ≤130mEq/L had been measured. All variables collected in the HN registry were included in the data base. All available information on ingested or administered solutes was recorded. Linear mixed effects models were applied to conduct multivariable repeated measures analyses. Following questions are to be answered in this study 1. Is the baseline sodium level a predominant factor determining the rapidity of sodium increase? 2. Ist he rapidity of sodium increase correlated to the given treatment? 3. Can other predominant factors of slope of sodium increase be determined?

Conditions

Timeline

Start date
2021-12-01
Primary completion
2022-03-31
Completion
2022-03-31
First posted
2022-03-14
Last updated
2023-05-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05277584. Inclusion in this directory is not an endorsement.